References
- Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait . Neurology. 1968;18(7):671–680.
- La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy . Nature. 1991;352(6330):77–79.
- Katsuno M, Banno H, Suzuki K, et al. Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). Adv Exp Med Biol. 2010;685:64–74.
- Giorgetti E, Lieberman AP. Polyglutamine androgen receptor-mediated neuromuscular disease. Cell Mol Life Sci. 2016;73(21):3991–3999.
- Chahin N, Sorenson EJ. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve. 2009;40(1):126–129.
- Weber MA, Kinscherf R, Krakowski-Roosen H, et al. Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting? J Mol Med. 2007;85(8):887–896.
- Brooks BR. E1 Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the E1 Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124:96–107.
- Sorarù G, D'Ascenzo C, Polo A, et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci. 2008;264(1–2):100–105.
- Cortes C, Ling SC, Guo L, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron. 2014;82(2):295–307.
- Sambataro F, Pennuto M. Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases. Prog Neurobiol. 2012;97(2):152– 172.
- Lieberman AP, Yu Z, Murray S, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014;7(3):774–784.
- Rocchi A, Milioto C, Parodi S, et al. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. 2016;132(1):127–144.
- Milioto C, Malena A, Maino E, et al. Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Sci Rep. 2017;7(1):41046
- Monks DA, Johansen JA, Mo K, et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci USA. 2007;104(46):18259–18264.
- Jordan C, Lieberman A. Spinal and bulbar muscular muscular atrophy: a motoneuron or muscle disease? Curr Opin Pharmacol. 2008;8(6):752– 758.
- Felice KJ, North WA. Creatine kinase values in amyotrophic lateral sclerosis. J Neurol Sci. 1998;160(Suppl 1):S30–S2.
- Cartwright R, Newton C, West KM, et al. Tracking the Development of Muscular Myoglobin Stores in Mysticete Calves. PLoS One. 2016;11(1):e0145893
- Garry DJ, Mammen PP. Molecular insights into the functional role of myoglobin. Adv Exp Med Biol. 2007;618:181–193.
- Moselhy SS, Demerdash SH. Serum free L-carnitine in association with myoglobin as a diagnostic marker of acute myocardial infarction. Clin Biochem. 2009;42(1–2):78–82.
- Araki A, Katsuno M, Suzuki K, et al. Brugada syndrome in spinal and bulbar muscular atrophy. Neurology. 2014;82(20):1813–1821.
- Querin G, Melacini P, D'Ascenzo C, et al. No evidence of cardiomyopathy in spinal and bulbar muscular atrophy. Acta Neurol Scand. 2013;128(6):e30–e32.
- Huang H, Zhu S, Wang W, et al. Diagnosis of acute myocardial infarction in patients with renal insufficiency using high-sensitivity troponin T. Clin Chem Lab Med. 2015;53(5):723–730.
- Parboosingh JS, Figlewicz DA, Krizus A, et al. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology. 1997;49(2):568–572.
- Hama T, Hirayama M, Hara T, et al. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Muscle Nerve. 2012;45(2):169–174.
- Suzuki K, Katsuno M, Banno H, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2007;131(1):229–239.
- Hashizume A, Katsuno M, Suzuki K, et al. A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. Neuromuscul Disord. 2015;25(7):554–562.
- Lu M, Guo H, Fan D. Kennedy's disease 1234 scale: preliminary design and test. J Clin Neurosci. 2017;S0967-5868(16):30717–30712. pii [Epub ahead of print]